Index of artpub/2022/280853/

Eggermont, Alexander M
PIVOT-12 : a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence
2022
https://ddd.uab.cat/record/280853